LONDON , April 29, 2024 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany , a leading science and technology company, today announced the launch of ...
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we will be ...
SUZHOU, China , April 26, 2024 /PRNewswire/ -- Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's ...
The second DMC review recommends the continuation of dose escalation in the clinical trial as per protocol. The interim safety assessment was based on the review of safety data from 18 metastatic gastrointestinal cancer patients, including ...
SHANGHAI , April 25, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase I/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...
HOLON, Israel , April 25, 2024 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE:CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it will present new ...
SAN DIEGO and WUHAN, China , April 23, 2024 /PRNewswire/ -- HanxBio today announced that it has published a research article titled " Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows ...
Financing co-led by Forbion, HealthCap and new investor Bioqube Ventures Funds will be used for pivotal trial of potential best-in-class, next-generation treatment for Tenosynovial Giant Cell Tumour DUBLIN and OXFORD, England , ...
The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, care partners and thrivers. This year we will be hosting ...
SHANGHAI , April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the ...
Mice fed a vitamin D-rich diet displayed enhanced immune resistance against experimentally transplanted cancers and showed improved responses to immunotherapy. Similar outcomes were observed when a protein binding vitamin D in the blood, thus ...
The research has revealed the considerable potential of tai chi as a non-pharmacological approach to improve survival rates in advanced lung cancer patients. It underscores the importance of incorporating ...
New research analyzing data from nearly 600,000 cancer patients in England reveals that survivors of breast cancer face a heightened risk of developing secondary...
Ethylene oxide, known for its carcinogenic properties, heightens the risk of breast cancer and causes DNA damage, affecting brain and nervous system function in humans. Recent findings reveal its presence in four products from two major spice brands ...
US researchers have pioneered a novel immunotherapy approach utilizing cytokine proteins as a promising treatment, precisely targeting tumors while sparing healthy cells from harm...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers